Quality assurance risks arising from product defects
First written in FY2019. 13 of 14 entries say "Restated". Latest entry: FY2025-H1.
- FY2025-H1RestatedAnnual report
「No new business or other risks arose during the interim consolidated accounting period. There were also no material changes to the business and other risks described in the annual securities report for the previous fiscal year.」
The Group states that there have been no material changes regarding quality assurance risk arising from product defects. - FY2024-Q3RestatedAnnual report
「During the cumulative third quarter of the fiscal year under review, there were no newly arising business or other risks. There were also no material changes to the business or other risks described in the annual securities report for the previous fiscal year.」
The Group states that there have been no material changes regarding quality assurance risk arising from product defects. - FY2024-Q2RestatedAnnual report
「No new business or other risks arose during the 2nd quarter cumulative period. There were also no material changes to the business and other risks described in the securities report for the previous fiscal year.」
The Group states that there have been no material changes regarding quality assurance risk arising from product defects. - FY2023-Q3RestatedAnnual report
「During the cumulative third quarter of the fiscal year under review, there were no newly arising business or other risks. There were also no material changes to the business or other risks described in the annual securities report for the previous fiscal year.」
The Group states that there have been no material changes regarding quality assurance risk arising from product defects. - FY2023-Q2RestatedAnnual report
「No new business or other risks arose during the 2nd quarter cumulative period. There were also no material changes to the business and other risks described in the securities report for the previous fiscal year.」
The Group states that there have been no material changes regarding quality assurance risk arising from product defects. - FY2022-Q1RestatedAnnual report
「No new business or other risks arose during the 1st quarter cumulative period. There were also no material changes to the risks described in the securities report for the previous fiscal year.」
The Group states that there have been no material changes regarding quality assurance risk arising from product defects. - FY2021RestatedAnnual report
「The Group has established a dedicated quality assurance department to manage product quality. However, there is no guarantee that all products will be free of defects or that no losses will arise in the future. Depending on the nature of a defect, external costs and product evaluations could be affected, potentially having an adverse effect on the Group’s operating results and financial position.」
While managing quality through its dedicated quality assurance department, the Group continues to identify the impact of product defects on costs and evaluations as a risk. - FY2021-Q3RestatedAnnual report
「During the cumulative third quarter of the fiscal year under review, there were no newly arising business or other risks. There were also no material changes to the business or other risks described in the annual securities report for the previous fiscal year.」
The Group states that there have been no material changes regarding quality assurance risk arising from product defects. - FY2021-Q2RestatedAnnual report
「No new business or other risks arose during the 2nd quarter cumulative period. There were also no material changes to the business and other risks described in the securities report for the previous fiscal year.」
The Group states that there have been no material changes regarding quality assurance risk arising from product defects. - FY2021-Q1RestatedAnnual report
「No new business or other risks arose during the 1st quarter cumulative period. There were also no material changes to the risks described in the securities report for the previous fiscal year.」
The Group states that there have been no material changes regarding quality assurance risk arising from product defects. - FY2020-Q3RestatedAnnual report
「During the cumulative third quarter of the fiscal year under review, there were no newly arising business or other risks. There were also no material changes to the business or other risks described in the annual securities report for the previous fiscal year.」
The Group states that there have been no material changes from the risk disclosures for the previous fiscal year regarding quality assurance risk arising from product defects. - FY2020-Q2RestatedAnnual report
「No new business or other risks arose during the 2nd quarter cumulative period. There were also no material changes to the business and other risks described in the securities report for the previous fiscal year.」
The Group states that there have been no material changes from the risk disclosures for the previous fiscal year regarding quality assurance risk arising from product defects. - FY2020-Q1RestatedAnnual report
「No new business or other risks arose during the 1st quarter cumulative period. There were also no material changes to the risks described in the securities report for the previous fiscal year.」
The Group states that there have been no material changes from the risk disclosures for the previous fiscal year regarding quality assurance risk arising from product defects. - FY2019First statedAnnual report
「The Group has established a dedicated quality assurance department to manage product quality. However, there is no guarantee that all products will be free of defects or that no losses will arise in the future.」
While managing quality through its dedicated quality assurance department, the Group identifies external costs arising from product defects and the impact on product evaluations as risks.